secwatch.observer — SEC 8-K summary
======================================

Issuer:     Virpax Pharmaceuticals, Inc. (—)
CIK:        0001708331
Form:       8-K
Filed at:   2025-02-06T23:59:59+00:00
Accession:  0001731122-25-000178
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Virpax appoints Charn Deol to board; Jaydriane Panis resigns
------------------------------------------------------------

- Jaydriane Panis resigned from board on Feb 3, 2025; Charn Deol appointed Feb 5, 2025.
- Deol appointed Chair of Audit Committee, member of Compensation and Nominating Committees.
- Deol receives CAD $3,000/month consulting fee payable to Spiral Investment Corp., his company.
- Deol has over 35 years public company experience, currently director/CFO at several companies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708331/000173112225000178/0001731122-25-000178-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708331/000173112225000178/e6344_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-25-000178

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer